BeOne Medicines AG (HKG:6160)

BeOne Medicines AG Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	313,186	152,765	147,345	178,113	217,115	182,154
Market Cap Growth	65.55%	3.68%	-17.27%	-17.96%	19.19%	130.77%
Enterprise Value	289,608	139,855	128,433	152,805	192,027	147,528
Last Close Price	216.60	109.20	110.10	134.20	161.00	157.00
PS Ratio	8.09	5.16	7.67	16.13	23.67	76.06
PB Ratio	9.75	5.90	5.33	5.21	4.54	6.07
P/TBV Ratio	9.90	5.99	5.42	5.26	4.58	6.08
P/OCF Ratio	51.25	-	-	-	-	-
EV/Sales Ratio	7.45	4.72	6.69	13.84	20.94	61.60
Debt / Equity Ratio	0.25	0.32	0.26	0.14	0.11	0.14
Net Debt / Equity Ratio	-0.73	-0.46	-0.63	-0.90	-0.97	-1.06
Net Debt / EBITDA Ratio	-9.19	3.85	1.99	2.28	4.25	2.52
Net Debt / FCF Ratio	-5.54	2.44	1.30	2.16	3.80	2.92
Asset Turnover	0.74	0.65	0.40	0.19	0.17	0.09
Inventory Turnover	1.43	1.30	1.09	1.09	0.99	23.18
Quick Ratio	2.09	1.51	1.97	3.22	4.45	4.40
Current Ratio	2.39	1.80	2.32	3.55	4.76	4.61
Return on Equity (ROE)	1.81%	-18.77%	-22.26%	-38.11%	-29.15%	-67.19%
Return on Assets (ROA)	1.69%	-6.07%	-12.40%	-15.00%	-12.72%	-28.73%
Return on Capital Employed (ROCE)	3.50%	-15.40%	-30.30%	-36.40%	-20.70%	-36.60%
Earnings Yield	0.17%	-3.28%	-4.67%	-8.77%	-5.24%	-6.92%
FCF Yield	1.35%	-3.22%	-9.12%	-7.98%	-5.61%	-5.96%
Buyback Yield / Dilution	-6.60%	-0.86%	-1.22%	-11.15%	-11.16%	-38.99%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.